Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology, today announced participation in a panel discussion at the B. Riley Securities Precision Oncology & Radiopharma Investor Conference that will ...

Your immune system harbors a lifetime's worth of information about threats it's encountered - a biological Rolodex of baddies ...

Receptors on B and T cells hint at what the immune system is targeting. An AI approach called Mal-ID developed increases diagnostic accuracy, particularly for autoimmune diseases.

Stanford University researchers developed a machine learning-based method capable of diagnosing multiple diseases using B cell and T cell receptor sequences. The model, called Machine learning for ...

“I am thrilled to join Werewolf’s board of directors as the company advances its novel INDUKINE molecules through clinical development,” said Dr. Singhal. “Werewolf is demonstrating the power of the ...

Findings from the implanted scaffold led researchers to block specific inflammatory molecules, easing disease severity in a ...

The concept of using vaccines to treat cancers has been around for several decades. A vaccine was first approved for prostate ...

About Kymera Therapeutics Kymera is a clinical-stage biotechnology company pioneering the field of targeted protein degradation (TPD) to develop medicines that address critical health problems and ...

Mal-ID – can decipher an individual’s immune system’s record of past infections and diseases, according to a new study, providing a powerful tool with the potential for diagnosing autoimmune disorders ...

“This study aimed to present clinical and immunological features in patients with neuroimmune complications of COVID-19 during the Omicron wave in China,” the authors wrote. Read more about the ...

Guillain-Barre Syndrome (GBS) is a condition when the body's immune system attacks the nerves. Weakness and tingling in the hands and feet are usually the first symptoms of GBS. Pins and needles ...